A STUDY OF THE CIRCULATING FIBROBLAST GROWTH FACTOR 21 AS A NOVEL NONINVASIVE BIOMARKER OF HEPATIC INJURY IN GENOTYPE-4 CHRONIC HEPATITIS C: EGYPTIAN PATIENTS AND THEIR RESPONSE TO DIRECT-ACTING ANTIVIRAL AGENTS
Account has been disabled due to a violation of Terms of Service.